- Home
- NCLH vs ASND Comparison
NCLH vs ASND Comparison
Compare NCLH & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCLH
- ASND
- Stock Information
- Founded
- NCLH 1966
- ASND 2006
- Country
- NCLH United States
- ASND Denmark
- Employees
- NCLH N/A
- ASND N/A
- Industry
- NCLH Marine Transportation
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- NCLH Consumer Discretionary
- ASND Health Care
- Exchange
- NCLH Nasdaq
- ASND Nasdaq
- Market Cap
- NCLH 10.1B
- ASND 10.6B
- IPO Year
- NCLH 2013
- ASND 2015
- Fundamental
- Price
- NCLH $25.05
- ASND $194.30
- Analyst Decision
- NCLH Buy
- ASND Strong Buy
- Analyst Count
- NCLH 19
- ASND 16
- Target Price
- NCLH $27.89
- ASND $239.88
- AVG Volume (30 Days)
- NCLH 15.3M
- ASND 566.6K
- Earning Date
- NCLH 07-31-2025
- ASND 08-07-2025
- Dividend Yield
- NCLH N/A
- ASND N/A
- EPS Growth
- NCLH 61.59
- ASND N/A
- EPS
- NCLH 1.54
- ASND N/A
- Revenue
- NCLH $9,560,994,000.00
- ASND $576,332,355.00
- Revenue This Year
- NCLH $8.52
- ASND $101.37
- Revenue Next Year
- NCLH $10.12
- ASND $76.17
- P/E Ratio
- NCLH $16.26
- ASND N/A
- Revenue Growth
- NCLH 5.22
- ASND 54.50
- 52 Week Low
- NCLH $14.21
- ASND $111.09
- 52 Week High
- NCLH $29.29
- ASND $199.99
- Technical
- Relative Strength Index (RSI)
- NCLH 58.89
- ASND 62.30
- Support Level
- NCLH $23.13
- ASND $191.44
- Resistance Level
- NCLH $24.92
- ASND $197.35
- Average True Range (ATR)
- NCLH 0.71
- ASND 7.99
- MACD
- NCLH -0.16
- ASND 0.18
- Stochastic Oscillator
- NCLH 81.70
- ASND 77.06
About NCLH Norwegian Cruise Line Holdings Ltd.
Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 70,000). It operates 33 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 12 passenger vessels on order among its brands through 2036, representing 37,500 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.